OPEN END TURBO OPTIONSSCHEIN LONG - COOPER COMPANIES Stock

Certificat

DE000GQ8J637

Real-time BOERSE MUENCHEN 14:35:51 2024-05-22 EDT
0.483 EUR -0.82% Intraday chart for OPEN END TURBO OPTIONSSCHEIN LONG - COOPER COMPANIES
Current month+94.76%
1 month+64.29%
Date Price Change
24-05-22 0.483 -0.82%
24-05-21 0.487 -6.35%
24-05-20 0.52 +1.17%
24-05-17 0.514 -3.38%
24-05-15 0.532 +17.70%

Real-time BOERSE MUENCHEN

Last update May 22, 2024 at 02:35 pm

More quotes

Static data

Product typeKnock-Out without Stop Loss
Buy / SellCALL
Underlying THE COOPER COMPANIES, INC.
Issuer Goldman Sachs
WKN GQ8J63
ISINDE000GQ8J637
Date issued 2023-11-03
Strike 83.9 $
Maturity Unlimited
Parity 25 : 1
Emission price 0.13
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 0.902
Lowest since issue 0.08

Company Profile

The Cooper Companies, Inc. is a global medical device company. The Company operates through two business units: CooperVision and CooperSurgical. CooperVision is engaged in the contact lens industry. CooperVision’s products include MyDay daily disposable, MyDay daily disposable toric, MyDay Energys, MyDay multifocal, Biofinity & Biofinity XR, Biofinity Energys, Biofinity toric & Biofinity XR toric, Biofinity multifocal, Biofinity toric multifocal, clariti 1 day, clariti 1 day toric, clariti 1 day multifocal, MiSight 1 day, Avaira Vitality and Avaira Vitality toric. CooperSurgical is a fertility and women’s health company dedicated to assisting women, babies and families around the world. CooperSurgical provides a range of products and services with an emphasis on improving fertility solutions, empowering office-based care, and advancing hospital care within women’s health. CooperSurgical’s brands include Paragard, ER-Complete, Fetal Pillow, INSORB, PGT-Complete, RUMI II and others.
Sector
-
More about the company

Ratings for The Cooper Companies, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: The Cooper Companies, Inc.

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
19
Last Close Price
96.6 USD
Average target price
107.9 USD
Spread / Average Target
+11.69%
Consensus